Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;49(11):3849-54.
doi: 10.1128/JCM.00619-11. Epub 2011 Sep 14.

Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States

Jennifer M Adams-Haduch  1 , Ezenwa O Onuoha, Tatiana Bogdanovich, Guo-Bao Tian, Jonas Marschall, Carl M Urban, Brad J Spellberg, Diane Rhee, Diane C Halstead, Anthony W Pasculle, Yohei Doi
Affiliations

Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States

Jennifer M Adams-Haduch et al. J Clin Microbiol. 2011 Nov.

Abstract

Acinetobacter baumannii is emerging as an important nosocomial pathogen worldwide. We report molecular epidemiology of 65 carbapenem-nonsusceptible A. baumannii isolates identified from hospitals in New York, Pennsylvania, Florida, Missouri, Nevada, and California between 2008 and 2009. All isolates were subjected to pulsed-field gel electrophoresis (PFGE). Select isolates then underwent multilocus sequence typing (MLST). While the PFGE patterns tended to cluster within each hospital, sequence types (STs) belonging to the clonal complex 92 (CC92) and the pan-European clonal lineage II (EUII; worldwide clonal lineage 2) were predominant in all hospitals. Of them, ST122 and ST208 were the most common and were found in four of the six hospitals. Isolates belonging to the pan-European clonal lineages I and III were identified in one hospital each. Carbapenemase-encoding genes bla(OXA-23) and/or ISAba1-bla(OXA-51-like) were present among the majority of isolates. These findings suggest that carbapenem-nonsusceptible A. baumannii isolates found in U.S. hospitals constitute part of the global epidemic driven by CC92, but have unique STs other than ST92, which may be spreading by means of patient transfer between health care facilities within the United States.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
PFGE and MLST results from the carbapenem-nonsusceptible study isolates. STs are based on the Bartual scheme.
See this image and copyright information in PMC

References

    1. Adams-Haduch J. M., et al. 2008. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob. Agents Chemother. 52:3837–3843 - PMC - PubMed
    1. Bartual S. G., et al. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382–4390 - PMC - PubMed
    1. Betrosian A. P., et al. 2007. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scand. J. Infect. Dis. 39:38–43 - PubMed
    1. Bratu S., et al. 2008. Correlation of antimicrobial resistance with β-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob. Agents Chemother. 52:2999–3005 - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms